Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient -...

62
Chapter 18

Transcript of Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient -...

Page 1: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Chapter 18

Page 2: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

DysfunctionInitially described

Excessive – hypersecretionInsufficient - hyposecretion

TodayAbnormal receptor functionAltered intracellular responseCirculating inhibitors* water-soluble hormones (not steroids –

lipid-soluble)

Page 3: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 4: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of the Hypothalamic – Pituitary System

“interruption of the pituitary stalk”

Destructive lesionsRupture after head injury Surgical transactionStem tumor

Page 5: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Loss of Hypothalamic Hormones

Page 6: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Posterior Pituitary

Syndrome of inappropriate anti-diuretic hormone secretion (SIADH)Hypersecretion of ADHEctopically produced (small cell carcinoma)Brain injury or infection (pulmonary

disease)Psychiatric/drugs

Water intoxication ( ↓Na+, hypo-osmolality)

Page 7: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Posterior Pituitary

Diabetes insipidusInsufficiency of ADHPolyuria and polydipsiaPartial or total inability to concentrate urineNeurogenic

Insufficient amounts of ADH

Nephrogenic Inadequate response to ADH

Psychogenic

Page 8: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 9: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior Pituitary

Hypopituitarism – “spectrum”

Pituitary infarctionSheehan syndrome ( pituitary necrosis)

HemorrhageShock Other: head trauma, infections and tumors

Page 10: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 11: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior Pituitary

Hypopituitarism Panhypopituitarism

ACTH deficiencyTSH deficiencyFSH & LH deficiencyGH deficiency

Page 12: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 13: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Dwarfism

Page 14: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior Pituitary

Hyperpituitarism Commonly caused by a benign slow- growing pituitary adenoma

ManifestationHeadache and fatigueVisual changesHyposecretion of neighboring anterior pituitary hormones

Page 15: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior Pituitary

Hypersecretion of growth hormone (GH)Acromegaly

Hypersecretion of GH during adulthood

Gigantism Hypersecretion of GH in children and

adolescents

Page 16: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior PituitaryHypersecretion of growth hormone (GH)

Page 17: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Gigantism

Page 18: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 19: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 20: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Barry Bonds HGH & Steroids

Page 21: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diseases of the Anterior PituitaryHypersecretion of prolactin

(most common)

Caused by prolactinomaIn females – amenorrhea, galactorrhea, hirsutism and osteopenia

In males – hypogonodism, erectile dysfunction, impaired libido, oligospermia and ↓ ejaculate volume

Page 22: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 23: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Thyroid Function

HyperthyroidismThyrotoxicosisGraves diseaseHyperthyroidism resulting from nodular thyroid diseaseGoiter

Thyrotoxic crisis

Page 24: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Common Causes ofHyperthyroidism

Page 25: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 26: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Thyroid FunctionHypothyroidism (most common)

PrimarySubacute thyroiditisAutoimmune thyroiditis (Hashimoto disease)

Painless thyroiditisPostpartum thyroiditisMyxedema coma

CongenitalThyroid carcinoma

Page 27: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Thyrotoxicosis: Graves Disease

Page 28: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Mechanism for Primary & Secondary Hypothyroidism

Page 29: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 30: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

MyxedemaOrbital Edema, Facial Puffiness,

Dry Skin

Page 31: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

HypothyroidismCongenital Hypothyroidism

“cretin”

Page 32: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Parathyroid Function

Hyperparathyroidism Primary

Excess secretion of PTH from one or more parathyroid gland

Secondary↑ PTH 2° to a chronic disease

Page 33: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 34: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Parathyroid Function

Hypopararthyroidism Abnormally low PTH levelsUsually caused by parathyroid damage in

thyroid surgery

Page 35: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Dysfunction of the Endocrine Pancreas

Diabetes Mellitus (Table 18-4)“group of disorders characterized by glucose intolerance”

DiagnosisRandom glucose > 200 mg/dlFBS > 126 mg/dl (8° fast)2 hour plasma glucose > 200 mg/dl

(75 gram OGTT)

Pre-diabetesIGT – impaired glucose tolerance - ↓ insulinIFG – impaired fasting glucose - ↑ hepatic glucose output

Glycosylated hemoglobin – HbA1cGoals

Maintain euglycemia, avoid hypoglycemiaPrevent severe cardiovascular and neurologic

complications

Page 36: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

International Diabetes Foundation366 million people worldwide have this

disease

4.6 million death per year due to diabetes

465 billion dollars per year

Association for the Study of Diabetes Annual Meeting, Lisbon Portugal, Sept. 2011

Page 37: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Dysfunction of the Endocrine Pancreas

Diabetes Mellitus Type 1

Pancreatic atrophy and specific loss of beta cells

Macrophages, T and B – lymphocytes, and natural killer (NK) cells are present

Two typesImmuneNon-immune

Page 38: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Type 1 Diabetes Mellitus

Page 39: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Type 1 Diabetes Mellitus Genetic susceptibility – HLA-DR3 & DR 4

Environmental Factors DrugsNutritional intakeViruses

Mumps, coxsackie, rubella, cytomegalovirus

Immunologically mediated destruction of beta cellsBeta cell autoantibodiesAntibodies to insulin

Manifestations Hyperglycemia, polydipsia, polyuria,

polyphagia, weight loss, and fatigue – Table 18.5

Page 40: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Type 2 Diabetes Mellitus Non-insulin dependent

More common (90%)Risk factors: obesity, family history, ethnic

minority, puberty, female and metabolic syndrome

CauseUnknown

Genetic susceptibility Environmental factors

Cellular resistance to insulinObesity↓Beta cell response to plasma glucoseAbnormal glucagon secretion

Page 41: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Type 2 Diabetes Mellitus Pathophysiology

CombinationExcess nutrients (glucose/fat) → beta cell apoptosis

ObesityInflammatory cytokinesObesity related (intra-abdominal fat) cytokines (adipokines) and ↑ FFA release

Major factors: insulin resistance and beta cell death

Page 42: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Gestational Diabetes“glucose intolerance appears during

pregnancy”Risk factors

Family historyHigh-risk ethnic groupAdvanced maternal age (> 25 years old)Prior historyPCO syndromeBMI > 25 kg/m2

Past obstetrical complications - GD

Page 43: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Acute Complications of Diabetes Mellitus (Table 18-7)

Hypoglycemia (45 to 50 mg/dl)90% Type 1Insulin shock or reaction

Diabetic ketoacidosisSerious↓Insulin → ↑ counter regulatory hormones

Catecholamines, cortisol, glucagon, growth hormone

Peaks in adolescence

Page 44: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

DKA & HHNKS

Page 45: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Acute Complications of Diabetes Mellitus

Hyperosmolar Hyperglycemic Nonketotic SyndromeType 2 – elderlyElevated serum glucose (500 mg/dl)Severe dehydration (↑↑ serum osmotic

pressure) → low blood volume ↓ BPKetosis – less common → insulin to # lipolysis

and protein catabolism

Somogyi effect – counter regulatory hormoneRebound hyperglycemia

Dawn phenomenon – GHEarly AM rise blood glucose

Page 46: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Chronic Complications of Diabetes Mellitus (Table 18-8)

Hyperglycemia and non-enzymatic glycosylation

Hyperglycemia and the polyol pathwayProtein kinase C

Microvascular diseaseRetinopathyDiabetic nephropathy

Page 47: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Chronic Complications of Diabetes Mellitus

Macrovascular disease (Type 2)Coronary artery diseaseStrokePeripheral artery disease

Diabetic neuropathiesInfection

Page 48: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 49: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 50: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 51: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 52: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 53: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Diabetes Mellitus & Atherosclerosis

Page 54: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 55: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Adrenal Function

Disorders of the adrenal cortex

Cushing diseaseExcessive anterior pituitary secretion of ACTH

Cushing syndromeExcessive level of cortisol regardless of cause

Page 56: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.
Page 57: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Cushing Disease

Page 58: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Adrenal Function Disorders of the adrenal cortex

HyperaldosteronismPrimary – Conn diseaseSecondary

Page 59: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Adrenal Function Disorders of the adrenal cortex

Adrenocortical hypofunctionPrimary (Addison disease)Idiopathic Addison disease Secondary hypocortisolism

Page 60: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Adrenal Function Disorders of the adrenal cortex

Hypersecretion of adrenal androgens and estrogensFeminizationVirilization

Page 61: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Virilization

Page 62: Chapter 18. Dysfunction Initially described Excessive – hypersecretion Insufficient - hyposecretion Today Abnormal receptor function Altered intracellular.

Alterations of Adrenal Function

Disorders of the adrenal medulla

HyperfunctionChromaffin cell tumorPheochromocytoma

Secretions of catecholamines on a continuous or episodic basis (norepinephrine)